Mortality risk from long-term treatment with antipsychotic polypharmacy vs monotherapy among adults with serious mental illness: A systematic review and meta-analysis of observational studies-Reference-Cited by-同舟云学术

Mortality risk from long-term treatment with antipsychotic polypharmacy vs monotherapy among adults with serious mental illness: A systematic review and meta-analysis of observational studies

Published:2020-09 Issue: Volume:223 Page:18-28
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Buhagiar Kurt^ORCID,Templeton Georgia,Blyth Henrietta,Dey Mrinalini^ORCID,Giacco Domenico

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference48 articles.

1. Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study;Baandrup;J. Clin. Psychiatry,2010

2. Polypharmacy for schizophrenia;Ballon;Curr. Opin. Psychiatry,2013

3. Recent physical conditions and health service utilization in people with common mental disorders and severe mental illness in England: comparative cross-sectional data from a nationally representative sample;Buhagiar;Eur. Psychiatry,2020

4. Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London;Chang;PLoS One,2011

5. Antipsychotics and risk of natural death in patients with schizophrenia;Chen;Neuropsychiatr. Dis. Treat.,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Antipsychotic Polypharmacy and Two-Year All-Cause Mortality: A Population-Based Cohort Study of 33,221 Italian Continuous Users;Journal of Clinical Medicine;2024-04-03

2. Drug Treatment of the Psychoses;Seminars in General Adult Psychiatry;2024-03-31

3. Associations between the number of antipsychotics prescribed and metabolic parameters in Japanese patients with schizophrenia;Psychiatry and Clinical Neurosciences Reports;2022-07-07

4. Antipsychotic polypharmacy and adverse drug reactions among adults in a London mental health service, 2008–2018;Psychological Medicine;2022-04-29

5. Antipsychotic Polypharmacy and High-Dose Antipsychotic Regimens in the Residential Italian Forensic Psychiatric Population (REMS);Frontiers in Psychology;2022-02-10